These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12911535)

  • 21. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
    Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
    Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
    Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
    Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
    Benigni A; Tomasoni S; Gagliardini E; Zoja C; Grunkemeyer JA; Kalluri R; Remuzzi G
    J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ; Ramsay LE; Hettiarachchi J
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats.
    Waanders F; van Goor H; Navis G
    Kidney Blood Press Res; 2008; 31(5):350-9. PubMed ID: 19018148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 2000 Mar; 57(3):992-1001. PubMed ID: 10720952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
    Yatsu T; Sanagi M; Fujimori A; Tomura Y; Hayashi K; Tanahashi M; Inagaki O
    Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
    Cinotti GA; Zucchelli PC;
    Nephrol Dial Transplant; 2001 May; 16(5):961-6. PubMed ID: 11328901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.
    Amara AB; Sharma A; Alexander JL; Alfirevic A; Mohiuddin A; Pirmohamed M; Close GL; Grime S; Maltby P; Shawki H; Heyworth S; Shenkin A; Smith L; Sharma AK; Hammad A; Rustom R
    Transplantation; 2010 Jan; 89(1):104-14. PubMed ID: 20061926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy.
    Mirkovic K; Frenay AS; van den Born J; van Goor H; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1293-1301. PubMed ID: 26311058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity.
    Ajibade TO; Awodele OA; Tijani MO; Adejumobi OA; Adetona MO; Oyagbemi AA; Adedapo AD; Omobowale TO; Aro AO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA
    Environ Sci Pollut Res Int; 2023 Feb; 30(9):23263-23275. PubMed ID: 36319925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A; Imberti O; Puntorieri S; Malanchini B; Macconi D; Magrini L; Bertani T; Remuzzi G
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease.
    Jia G; Kwon M; Liang HL; Mortensen J; Nilakantan V; Sweeney WE; Park F
    Pediatr Nephrol; 2010 Jun; 25(6):1139-46. PubMed ID: 20229187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats.
    Remuzzi A; Benigni A; Malanchini B; Bruzzi I; Foglieni C; Remuzzi G
    Kidney Int; 1995 May; 47(5):1319-26. PubMed ID: 7637261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.